tirzepatide glp 1 GLP-1 use tripled among non-diabetics, reaching $5.8B in 2022 Lose up to 20% of your body weight with this simple Semaglutide & Tirzepatide Weight Loss

The Link Between PCOS and GLP-1 In women with PCOS, insulin resistance and gut health imbalances may disrupt GLP-1 signaling, says Jennifer Nicole Bianchini, MS, RD, IFNCP, RYT, a functional dietitian and mind-body wellness expert

Both liraglutide and exendin-4 decrease the size, weight, and proliferation of pancreatic, breast, prostate, ovarian, intestinal, liver, and colon cancer

Zepbound, approved in late 2023, made $4.9 billion in 2024

The impact of GLP-1R agonists such as semaglutide extends beyond diabetes control: they play a multifaceted role in regulating blood glucose levels by reducing hunger, moderating food intake, and managing body weight [36]

Marguet D, Baggio L, Kobayashi T, Bernard AM, Pierres M, Nielsen PF, Ribel U, Watanabe T, Drucker DJ, and Wagtmann N

(But as the review points out, some research is conflicting.) Exactly whats going on needs further study